PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nanotechnology Research Centre, National Research Council Canada, 11421 Saskatchewan Drive, Edmonton, AB T6G 2A3, Canada.\', \'Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.\', \'Human Health Therapeutics Research Centre, National Research Council Canada, 1200 Montreal Road, Ottawa, ON K1A 0R6, Canada.\', \'Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1139/bcb-2020-0341
?:doi
?:hasPublicationType
?:journal
  • Biochemistry and cell biology = Biochimie et biologie cellulaire
is ?:pmid of
?:pmid
?:pmid
  • 33027600
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all